BIOTRONIK A Prospective Randomized Multicenter Study toAssess the SaFety and Effectiveness of the Orsiro SiroLimusEluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions V
A study for patients with Coronary Artery Disease (CAD) using the Orsiro Stent system
Sponsor: Biotronik Inc.
Enrolling: Male and Female Patients
IRB Number: AAAP2866
U.S. Govt. ID: NCT02389946
Contact: Lauren Privitera: 212-342-3488 / lp2183@cumc.columbia.edu
Additional Study Information: This study is for patients with Coronary Artery Disease (CAD) and require a stent placement. The purpose of this clinical research study is to assess the safety and effectiveness of the Orsiro stent or a non-investigational Xience stent. The Orsiro stent is investigational, which means it is not yet approved by the FDA and can only be used in research studies.
This study is closed
Investigator
Michael Collins, MD
Do You Qualify?
Do you have coronary artery disease? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Lauren Privitera
lp2183@cumc.columbia.edu
212-342-3488
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE